Skip to main content

CORRECTION article

Front. Cell. Infect. Microbiol., 15 January 2024
Sec. Parasite and Host

Corrigendum: Resistance and pseudo-resistance to permethrin phenomena: the importance of controlling scabies

Fabio RinaldiFabio RinaldiRoberta ChiricoRoberta ChiricoAnna TrinkAnna TrinkDaniela Pinto*Daniela Pinto*
  • HMAP, Human Microbiome Advanced Project, Milan, Italy

A Corrigendum on:
Resistance and pseudo-resistance to permethrin: the importance of controlling scabies.

By Rinaldi F, Chirico R, Trink A and Pinto D (2023) Front. Cell. Infect. Microbiol. 13:1297337. doi: 10.3389/fcimb.2023.1297337

Text Correction

In the published article, there was an error. A correction has been made to Resistance and Pseudo-resistance to Permetrhin, Causes of Resistance, paragraph one. This sentence previously stated:

“Moreover, within hours after exposure, all mites were dead, providing evidence of a genuine resistance to Permethrin.”.

The corrected sentence appears below:

“Moreover, within hours after exposure, all mites were dead, evidencing an absence of resistance to Permethrin.”.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: Sarcoptes scabiei var. hominis, permethrin, pseudoresistance, resistance, scabies

Citation: Rinaldi F, Chirico R, Trink A and Pinto D (2024) Corrigendum: Resistance and pseudo-resistance to permethrin phenomena: the importance of controlling scabies. Front. Cell. Infect. Microbiol. 13:1358427. doi: 10.3389/fcimb.2023.1358427

Received: 19 December 2023; Accepted: 29 December 2023;
Published: 15 January 2024.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2024 Rinaldi, Chirico, Trink and Pinto. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Daniela Pinto, dpinto@giulianipharma.com

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.